“Aspirin Cuts Pancreatic Cancer Risk by Half, Study Finds,” Bloomberg

A recent study from Yale Cancer Center/Smilow Cancer Hospital found that Regular aspirin use cut the risk of pancreatic cancer by half, according to a finding that adds one of the most lethal malignancies to the list of diseases the inexpensive pill may help fight. Yale Cancer Center/Smilow Cancer Hospital is one of the 25 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news